Abstract #301567

This is the preliminary program for the 2003 Joint Statistical Meetings in San Francisco, California. Currently included in this program is the "technical" program, schedule of invited, topic contributed, regular contributed and poster sessions; Continuing Education courses (August 2-5, 2003); and Committee and Business Meetings. This on-line program will be updated frequently to reflect the most current revisions.

To View the Program:
You may choose to view all activities of the program or just parts of it at any one time. All activities are arranged by date and time.

The views expressed here are those of the individual authors
and not necessarily those of the ASA or its board, officers, or staff.


Back to main JSM 2003 Program page



JSM 2003 Abstract #301567
Activity Number: 180
Type: Contributed
Date/Time: Monday, August 4, 2003 : 2:00 PM to 3:50 PM
Sponsor: Biopharmaceutical Section
Abstract - #301567
Title: Optimal Estimator for the Survival Distribution for Treatment Policies in Two-Stage Randomization Designs in Clinical Trials
Author(s): Abdus Shakoor F. Wahed*+ and Anastasios A. Tsiatis
Companies: North Carolina State University and North Carolina State University
Address: 2900 ES King Village, Raleigh, NC, 27607,
Keywords: induction therapy ; influence functions ; iIntent-to-treat ; inverse probability weighted estimator ; missing data ; counterfactuals or potential outcomes
Abstract:

Two-stage designs, where patients are initially randomized to an induction therapy and then depending upon their response and consent, are randomized to a maintenance therapy, are common in cancer and other clinical trials. The goal is to compare different combinations of primary and maintenance therapies to find the combination that is most beneficial. In practice, the analysis is usually conducted in two separate stages which does not directly address the major objective of finding the best combination. Recently Lunceford et al. (2002) introduced ad hoc estimators for the survival distribution and mean restricted survival time under different treatment policies. These estimators do not include information from auxiliary covariates. We derive estimators that are easy to compute and are more efficient than previous estimators. We also show how to improve efficiency further by taking into account additional information from auxiliary variables. Large sample properties of these estimators are derived and comparisons with other estimators are made using simulation. We apply our estimators to a leukemia clinical trial dataset.


  • The address information is for the authors that have a + after their name.
  • Authors who are presenting talks have a * after their name.

Back to the full JSM 2003 program

JSM 2003 For information, contact meetings@amstat.org or phone (703) 684-1221. If you have questions about the Continuing Education program, please contact the Education Department.
Revised March 2003